We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$15.1B
AUM Growth
-$1.32B
(-8.1%)
Cap. Flow
-$1.84B
Cap. Flow
% of AUM
-12.19%
Top 10 Holdings %
Top 10 Hldgs %
6.07%
Holding
4,629
New
783
Increased
1,169
Reduced
1,303
Closed
1,222
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$66.7M |
| 2 |
MSCI
MSCI
|
+$54.1M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$46.5M |
| 4 |
ResMed
RMD
|
+$44.7M |
| 5 |
PPG Industries
PPG
|
+$43.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$74M |
| 2 |
L3Harris
LHX
|
+$69.6M |
| 3 |
Honeywell
HON
|
+$64.1M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$60.2M |
| 5 |
Wells Fargo
WFC
|
+$59.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.88% |
| 2 | Consumer Discretionary | 8.49% |
| 3 | Financials | 8.33% |
| 4 | Industrials | 8.18% |
| 5 | Healthcare | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
AngioDynamics
ANGO
$651M
| $580K | ﹤0.01% |
55,571
-7,773
| -12% | -$74.8K |
|
2302
CALL
Bloom Energy
BE
$62B
| $577K | ﹤0.01% |
35,300
+20,400
| +137% | +$330K |
|
|
NEX
2303
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $576K | ﹤0.01% |
+64,472
| New | +$532K |
|
2304
PUT
RingCentral
RNG
$5.38B
| $576K | ﹤0.01% |
17,600
-26,600
| -60% | -$817K |
|
2305
OptimizeRx
OPRX
$129M
| $576K | ﹤0.01% |
40,276
-53,746
| -57% | -$765K |
|
|
APLS
2306
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $574K | ﹤0.01% |
6,300
+1,700
| +37% | +$147K |
|
2307
CALL
CBRE Group
CBRE
$41.7B
| $573K | ﹤0.01% |
+7,100
| New | +$532K |
|
2308
Brookfield Renewable
BEP
$9.8B
| $572K | ﹤0.01% |
19,390
| – | – |
|
2309
SandRidge Energy
SD
$531M
| $572K | ﹤0.01% |
37,509
-12,323
| -25% | -$181K |
|
2310
PUT
Kraft Heinz
KHC
$29.6B
| $572K | ﹤0.01% |
16,100
-18,800
| -54% | -$723K |
|
2311
Victory Capital Holdings
VCTR
$6.85B
| $571K | ﹤0.01% |
18,102
-109,092
| -86% | -$3.37M |
|
2312
PUT
Children's Place
PLCE
$58.3M
| $569K | ﹤0.01% |
+24,500
| New | +$623K |
|
2313
Kiniksa Pharmaceuticals
KNSA
$5.97B
| $567K | ﹤0.01% |
+40,294
| New | +$539K |
|
|
CBAY
2314
DELISTED
Cymabay Therapeutics
CBAY
| $567K | ﹤0.01% |
51,745
-479,636
| -90% | -$4.47M |
|
2315
CALL
DexCom
DXCM
$33.1B
| $565K | ﹤0.01% |
4,400
+1,000
| +29% | +$121K |
|
2316
PUT
Sonos
SONO
$1.83B
| $565K | ﹤0.01% |
34,600
-5,200
| -13% | -$92.2K |
|
2317
CALL
Ingevity
NGVT
$2.65B
| $564K | ﹤0.01% |
+9,700
| New | +$582K |
|
2318
Warrior Met Coal
HCC
$5.04B
| $564K | ﹤0.01% |
14,471
-10,748
| -43% | -$389K |
|
2319
CALL
FMC
FMC
$1.31B
| $563K | ﹤0.01% |
+5,400
| New | +$607K |
|
2320
PUT
Factset
FDS
$10.1B
| $561K | ﹤0.01% |
1,400
-600
| -30% | -$242K |
|
|
FINV
2321
FinVolution Group
FINV
$1.11B
| $560K | ﹤0.01% |
121,834
+78,849
| +183% | +$324K |
|
2322
Zoetis
ZTS
$30.9B
| $560K | ﹤0.01% |
3,253
-86,106
| -96% | -$14.9M |
|
2323
CALL
Valaris
VAL
$5.94B
| $560K | ﹤0.01% |
+8,900
| New | +$536K |
|
2324
PUT
Chewy
CHWY
$9.25B
| $557K | ﹤0.01% |
+14,100
| New | +$491K |
|
|
PLMIU
2325
DELISTED
Plum Acquisition Corp. I Units
PLMIU
| $555K | ﹤0.01% |
52,919
-1,331
| -2% | -$13.9K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q2 2023 Portfolio in Review
As of Q2 2023, Cubist Systematic Strategies held 4,629 positions worth $15.1B, down 8.1% from $16.4B the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.
Cubist Systematic Strategies withdrew a net $1.84B in Q2 2023, closing 1,222 positions and reducing 1,303 holdings. Its most notable exit was Cigna, an estimated $74M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Cubist Systematic Strategies opened a new position in Atlassian worth $34.2M.
- Cubist Systematic Strategies's largest Q2 2023 buy was Atlassian: 203,897 shares worth $34.2M.
- Cubist Systematic Strategies added most to Alphabet (Google) Class A in Q2 2023, an estimated $66.7M increase.
- Cubist Systematic Strategies's biggest Q2 2023 reduction was L3Harris, cutting an estimated $69.6M.
- Cubist Systematic Strategies fully exited Cigna in Q2 2023, selling an estimated $74M.
- Cubist Systematic Strategies's ten largest holdings make up 6.1% of its $15.1B portfolio in Q2 2023.
- Cubist Systematic Strategies opened 783 new positions and closed 1,222 in Q2 2023.
- Cubist Systematic Strategies's portfolio value fell 8.1% quarter-over-quarter to $15.1B.
Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.